Healthcare / Health Information ServicesNYSE
$10.66
+0.80 (+8.11%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 33% · confianza 25%
FCF escenarios
weak_data · normalized FCF $8.3M · quality 46.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
44/100
C
Piotroski
6/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
20/100
SEC 0%
Sin guardar todavía.
Market Cap
$659M
P/E
66.6x
↑EV/EBITDA
23.2x
↑ROE
0.7%
↑Gross Margin
67.9%
↑Debt/Equity
0.30
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2018–2026 · 8 años de histórico normalizado
Revenue CAGR
+25.2%
FCF CAGR
—
FCF margin
11.3%
FCF / Net income
23.60x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $480.6M · net income $2.3M · FCF $54.4M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | $480.6M | $480.6M | $419.8M | $356.3M | $280.9M | $213.2M | $148.7M | $124.8M | $99.9M | $79.8M |
| Net Income | $2.3M | $2.3M | $-58.5M | $-136.9M | $-176.1M | $-118.2M | $-27.3M | $-20.3M | $-15.1M | $-18.2M |
| EBITDA | $29.5M | $29.5M | $-25.6M | $-104.0M | $-148.9M | $-95.5M | $-9.8M | $-1.4M | $2.1M | $-4.9M |
| EPS | 0.04 | 0.04 | -1.02 | -2.51 | -3.36 | -2.37 | -0.69 | -4.50 | — | — |
| Gross Margin | 67.9% | 67.9% | 67.9% | 65.2% | 61.1% | — | — | — | — | — |
| Operating Margin | -1.4% | -1.4% | -13.8% | -38.3% | -62.9% | -54.8% | -17.3% | -12.3% | -9.5% | -18.2% |
| Net Margin | 0.5% | 0.5% | -13.9% | -38.4% | -62.7% | -55.4% | -18.4% | -16.3% | -15.1% | -22.8% |
| Balance Sheet | ||||||||||
| Debt/Equity | 0.30 | 0.30 | 0.07 | 0.05 | 0.03 | 0.00 | 0.01 | 0.19 | -0.13 | — |
| Current Ratio | 1.76 | 1.76 | — | — | — | — | — | — | — | — |
| Cash Flow | ||||||||||
| Free Cash Flow | $54.4M | $54.4M | $8.3M | $-57.5M | $-116.3M | $-93.1M | $-8.4M | $-6.2M | $-6.9M | $-17.7M |
| Returns | ||||||||||
| ROE | 0.7% | 0.7% | -22.1% | -54.4% | -61.2% | -28.3% | -10.4% | -19.9% | 7.1% | 10.8% |
| Valuation | ||||||||||
| P/E | 66.63 | 66.63 | — | — | — | — | — | — | — | — |
| EV/EBITDA | 23.22 | 23.22 | — | — | — | — | — | — | — | — |
| P/B | 1.94 | 1.94 | 6.30 | 5.80 | 6.90 | — | — | — | — | — |
| Growth & Yield | ||||||||||
| Revenue Growth | 14.5% | 14.5% | 17.8% | 26.8% | — | 43.4% | 19.1% | 24.9% | 25.1% | — |
| EPS Growth | 103.9% | 103.9% | 59.4% | 25.3% | — | -243.5% | 84.7% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
187.0%
EPS terminal req.
$0.95
Spread vs growth
-83.1%
5Y implied EPS CAGR
95.6%
EPS terminal req.
$1.14
Spread vs growth
8.3%
10Y implied EPS CAGR
46.7%
EPS terminal req.
$1.84
Spread vs growth
57.2%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-56.5%
Start / end P/E
n/dx → n/dx
EPS bridge
-1.02 → 0.04
Residual
-56.5%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.